Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIR637 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DAPK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EEF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NMRK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIAS4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATCAY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBTB7A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZFR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MATK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL54 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APBA3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on